This article is more than 5 years old. Information may no longer be current.
Top Five Stories from the Interdisciplinary Autoimmune Summit
Click Here to Manage Email Alerts
Healio Rheumatology features the top stories from the Interdisciplinary Autoimmune Summit. More of Healio Rheumatology’s live coverage, including video interviews with researchers, can be found by clicking here.
Speaker: Biosimilars offer opportunity for increased patient access
NEW YORK — Biosimilars are highly similar to their respective reference products and are currently priced about 15% less, according to a presenter here at the Interdisciplinary Autoimmune Summit. Read More.
JAK inhibitors demonstrated efficacy comparable to TNF inhibitors
NEW YORK — At the Interdisciplinary Autoimmune Summit, investigators described the latest research on Janus kinase (JAK) inhibitors, which demonstrated these are effective and appear to be comparable to tumor necrosis factor inhibitors for rheumatoid arthritis. Read More.
VIDEO: Rheumatologists may miss patients with axial spondyloarthritis
NEW YORK — At the Interdisciplinary Autoimmune Summit, Atul A. Deodhar, MD, professor of medicine and medical director at the Oregon Health and Science University, spoke about the integration of care in spondyloarthritis to ensure these patients are not being missed. Read More.
VIDEO: Speaker reviews factors that impact response to treatment for Crohn’s disease, ulcerative colitis
NEW YORK — At the Interdisciplinary Autoimmune Summit, Steven B. Hanauer, MD, medical director of the Digestive Health Center at Northwestern University, Feinberg School of Medicine, talked about his presentation on strategies in the management of inflammatory bowel disease. Read More.
Speaker: Rheumatologists must be prepared for immune-mediated diseases
NEW YORK — While immune-mediated diseases cannot be prevented, rheumatologists must be ready to prepare for the critical decision-making that lies ahead, according to a presentation by Leonard H. Calabrese, DO, at the Interdisciplinary Autoimmune Summit. Read More.